SLC25A3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the SLC25A3 protein. SLC25A3, also known as phosphate carrier protein, is a member of the solute carrier family 25 (SLC25), which is involved in the transport of various molecules across the inner mitochondrial membrane. This protein plays a critical role in the mitochondrial transport system by facilitating the exchange of phosphate ions with hydroxyl ions. This exchange is essential for the production of ATP via oxidative phosphorylation, as phosphate is a key substrate in the synthesis of ATP, the primary energy currency of the cell.
Structurally, SLC25A3 inhibitors can include a wide range of molecules, such as small organic compounds, peptides, or larger biomolecules engineered to bind specifically to the transporter's active site or other regulatory regions. These inhibitors function by blocking the phosphate binding sites or altering the conformation of the SLC25A3 protein, thereby preventing the efficient transport of phosphate ions into the mitochondrial matrix. By inhibiting SLC25A3, these compounds can disrupt the mitochondrial phosphate transport mechanism, leading to altered mitochondrial function and energy production. The study of SLC25A3 inhibitors is crucial for understanding the intricacies of mitochondrial ion transport and the broader implications of ion homeostasis on cellular metabolism. Research into these inhibitors provides valuable insights into the regulation of mitochondrial function and the role of ion transporters in maintaining cellular energy balance. By exploring the effects of SLC25A3 inhibition, scientists can gain a deeper understanding of the physiological and biochemical pathways influenced by mitochondrial transport systems, highlighting the importance of these transporters in cellular bioenergetics and metabolic regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Carnitine | 541-15-1 | sc-205727 sc-205727A sc-205727B sc-205727C | 1 g 5 g 100 g 250 g | $23.00 $34.00 $79.00 $179.00 | 3 | |
Carnitine might inhibit SLC25A by interfering with its substrate transport function, possibly by competing for binding to the transporter or disrupting its conformation. | ||||||
Bongkrekic acid | 11076-19-0 | sc-205606 | 100 µg | $400.00 | 10 | |
Bongkrekic acid inhibits the adenine nucleotide translocase, a member of the SLC25A family, thereby indirectly affecting SLC25A. | ||||||
Elacridar | 143664-11-3 | sc-207613A sc-207613 sc-207613B sc-207613C sc-207613D | 5 mg 10 mg 50 mg 100 mg 1 g | $98.00 $113.00 $411.00 $525.00 $2606.00 | 19 | |
Elacridar inhibits various solute carriers and can potentially influence the function of SLC25A. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $250.00 | 3 | |
Valinomycin disrupts mitochondrial membrane potential, potentially affecting transport proteins like SLC25A. | ||||||
Tenofovir | 147127-20-6 | sc-204335 sc-204335A | 10 mg 50 mg | $157.00 $646.00 | 11 | |
Tenofovir affects mitochondrial nucleotide transport, which may have an indirect effect on SLC25A. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glucose analog interferes with glycolysis and can influence mitochondrial transport proteins, including SLC25A. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $67.00 $126.00 $251.00 $465.00 | 13 | |
Mdivi-1 inhibits mitochondrial division, potentially influencing mitochondrial transporters like SLC25A. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Rotenone inhibits mitochondrial electron transport chain, potentially impacting transport proteins like SLC25A. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
Antimycin A disrupts electron transport chain, which can influence mitochondrial solute carriers including SLC25A. | ||||||